Versatile Whey Acidic Protein Four-disulfide Core Domain Proteins: Biology and Role in Diseases

Overview

Journal Front Cell Dev Biol

Specialty Cell Biology

Date 2024 Sep 19

PMID 39296934

Authors

Yifan Wen

Nan Jiang

Zhen Wang

Yuanyuan Xiao

Affiliations

Soon will be listed here.

Abstract

The Whey acidic protein four-disulfide core (WFDC) protein family consists of proteins with one or more WFDC domains which are ubiquitously expressed throughout the body of human and perform a wide range of functions, including antiprotease, antibacterial, and immunomodulatory functions. Aberrant expression of WFDC proteins is associated with human diseases. However, review on the WFDC protein family is limited and insufficient. Furthermore, a systematic summary of the underlying mechanisms of WFDC protein activity is lacking. In this review, we give a summary of the structural basis and molecular function of these proteins and review the immune regulatory mechanisms and signaling pathways of WFDC proteins in the development of certain diseases. Furthermore, we discuss the diagnostic and prognostic potential of multiple WFDC proteins in the aforementioned conditions, as well as their prospective use. At last, we also discuss the progress of WFDC protein in clinical trials and put forward some research difficulties and the directions of follow-up research. Our review highlights the functional diversity and clinical significance of WFDC proteins family, while providing potential targets for drug development and innovative therapeutic strategies, this review lays the foundation and direction for future research on WFDC proteins.

References

Drapkin R, von Horsten H, Lin Y, C Mok S, Crum C, Welch W . Human epididymis protein 4 (HE4) is a secreted glycoprotein that is overexpressed by serous and endometrioid ovarian carcinomas. Cancer Res. 2005; 65(6):2162-9. DOI: 10.1158/0008-5472.CAN-04-3924. View

Sano C, Shimizu T, Sato K, Kawauchi H, Tomioka H . Effects of secretory leucocyte protease inhibitor on the production of the anti-inflammatory cytokines, IL-10 and transforming growth factor-beta (TGF-beta), by lipopolysaccharide-stimulated macrophages. Clin Exp Immunol. 2000; 121(1):77-85. PMC: 1905674. DOI: 10.1046/j.1365-2249.2000.01269.x. View

Yang H, Gao D, Wang C, Jiao J, Yu X, Li X . Effect of different metastasis patterns on the prognosis of patients with stage III high-grade serous ovarian cancer. Am J Cancer Res. 2023; 13(8):3599-3606. PMC: 10492114. View

Ma G, Greenwell-Wild T, Lei K, Jin W, Swisher J, Hardegen N . Secretory leukocyte protease inhibitor binds to annexin II, a cofactor for macrophage HIV-1 infection. J Exp Med. 2004; 200(10):1337-46. PMC: 2211913. DOI: 10.1084/jem.20041115. View

Bingle C, Vyakarnam A . Novel innate immune functions of the whey acidic protein family. Trends Immunol. 2008; 29(9):444-53. DOI: 10.1016/j.it.2008.07.001. View

Piek A, Meijers W, Schroten N, Gansevoort R, de Boer R, Sillje H . HE4 Serum Levels Are Associated with Heart Failure Severity in Patients With Chronic Heart Failure. J Card Fail. 2016; 23(1):12-19. DOI: 10.1016/j.cardfail.2016.05.002. View

Nagy Jr B, Bhattoa H, Steiber Z, Csoban M, Szilasi M, Mehes G . Serum human epididymis protein 4 (HE4) as a tumor marker in men with lung cancer. Clin Chem Lab Med. 2014; 52(11):1639-48. DOI: 10.1515/cclm-2014-0041. View

Gibbons A, McElvaney N, Cryan S . A dry powder formulation of liposome-encapsulated recombinant secretory leukocyte protease inhibitor (rSLPI) for inhalation: preparation and characterisation. AAPS PharmSciTech. 2010; 11(3):1411-21. PMC: 2974130. DOI: 10.1208/s12249-010-9500-2. View

Henriksen P . The potential of neutrophil elastase inhibitors as anti-inflammatory therapies. Curr Opin Hematol. 2013; 21(1):23-8. DOI: 10.1097/MOH.0000000000000001. View

10.

Li B, Lou E, Hsu M, Yu H, Naidoo J, Zauderer M . Serum Biomarkers Associated with Clinical Outcomes Fail to Predict Brain Metastases in Patients with Stage IV Non-Small Cell Lung Cancers. PLoS One. 2016; 11(1):e0146063. PMC: 4701719. DOI: 10.1371/journal.pone.0146063. View

11.

Trexler M, Banyai L, Patthy L . Distinct expression pattern of two related human proteins containing multiple types of protease-inhibitory modules. Biol Chem. 2002; 383(1):223-8. DOI: 10.1515/BC.2002.023. View

12.

Zhong H, Qian Y, Fang S, Yang L, Li L, Gu W . HE4 expression in lung cancer, a meta-analysis. Clin Chim Acta. 2017; 470:109-114. DOI: 10.1016/j.cca.2017.05.007. View

13.

Gao L, Cheng H, Dong L, Ye X, Liu Y, Chang X . The role of HE4 in ovarian cancer: inhibiting tumour cell proliferation and metastasis. J Int Med Res. 2011; 39(5):1645-60. DOI: 10.1177/147323001103900507. View

14.

Bingle L, Cross S, High A, Wallace W, Rassl D, Yuan G . WFDC2 (HE4): a potential role in the innate immunity of the oral cavity and respiratory tract and the development of adenocarcinomas of the lung. Respir Res. 2006; 7:61. PMC: 1459147. DOI: 10.1186/1465-9921-7-61. View

15.

Rajakumar A, Chu T, Handley D, Bunce K, Burke B, Hubel C . Maternal gene expression profiling during pregnancy and preeclampsia in human peripheral blood mononuclear cells. Placenta. 2010; 32(1):70-8. PMC: 3040985. DOI: 10.1016/j.placenta.2010.10.004. View

16.

Korkmaz E, Koksal D, Aksu F, Dikmen Z, Icen D, Maden E . Triple test with tumor markers CYFRA 21.1, HE4, and ProGRP might contribute to diagnosis and subtyping of lung cancer. Clin Biochem. 2018; 58:15-19. DOI: 10.1016/j.clinbiochem.2018.05.001. View

17.

Sallenave J . Secretory leukocyte protease inhibitor and elafin/trappin-2: versatile mucosal antimicrobials and regulators of immunity. Am J Respir Cell Mol Biol. 2010; 42(6):635-43. DOI: 10.1165/rcmb.2010-0095RT. View

18.

Arrais M, Lulua O, Quifica F, Rosado-Pinto J, Gama J, Taborda-Barata L . Prevalence of asthma, allergic rhinitis and eczema in 6-7-year-old schoolchildren from Luanda, Angola. Allergol Immunopathol (Madr). 2019; 47(6):523-534. DOI: 10.1016/j.aller.2018.12.002. View

19.

Kramps J, van Twisk C, Appelhans H, Meckelein B, Nikiforov T, Dijkman J . Proteinase inhibitory activities of antileukoprotease are represented by its second COOH-terminal domain. Biochim Biophys Acta. 1990; 1038(2):178-85. DOI: 10.1016/0167-4838(90)90202-q. View

20.

McMurray J, Adamopoulos S, Anker S, Auricchio A, Bohm M, Dickstein K . ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the.... Eur J Heart Fail. 2012; 14(8):803-69. DOI: 10.1093/eurjhf/hfs105. View